Navigation Links
Mindray Announces Option Exchange Offer
Date:3/11/2009

SHENZHEN, China, March 11 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has authorized an option exchange program for certain options granted under the Mindray Medical International Limited Share Incentive Plan (the "Share Incentive Plan"). This exchange program, which is only available to eligible employees, is expected to provide additional incentive and retention value.

Under the terms of the exchange, participants will be able to tender vested and unvested outstanding options to purchase Class A ordinary shares of Mindray which have an exercise price greater than $24.00 per share in exchange for a lower number of newly granted options. The exercise price of the new options will be the closing price of Mindray common stock on the New York Stock Exchange on the exchange date. Mindray expects the offer to expire on March 15, 2009 and expects to grant the replacement options on March 16, 2009. The option exchange program is designed so that the current fair value of the options surrendered is similar to the fair value of the replacement options, and any additional expenses due to the exchange offer should be minimal.

Cautionary Note Regarding Forward-Looking Statements

This press release contains "forward-looking statements" related to our offer to exchange certain stock options for replacement options. These statements are not historical facts but instead represent only our belief regarding future events, many of which, by their nature, are inherently uncertain and outside of our control. Such information speaks only as of the date of this announcement, and we undertake no obligation to update or revise these forward-looking statements, wheth
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Mindray to Report Fourth Quarter and Fiscal Year 2008 Financial Results on March 4, 2009
2. Mindray Medical Achieves 2008 Product Development Goals and Announces Strong Pipeline for 2009
3. Mindray Announces Preliminary 2008 Operating Results
4. Mindray Medical to Present at the 27th Annual J.P. Morgan Healthcare Conference
5. Mindray Medical to Exhibit at RSNA 2008 in Chicago, from November 30th to December 4th, 2008
6. Mindray Announces 2008 Third Quarter and Nine Months Results
7. Mindray to Report Third Quarter 2008 Financial Results on November 11, 2008
8. Mindray Medical to Exhibit New Products at 60th China International Medical Equipment Fair
9. Mindray Releases Historical Financial Results Converted into US Dollar Terms
10. Mindray to Unveil Three New Products and Reagents at AACC Annual Meeting
11. Mindray Announces 20-F Filing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...NAPOLIS Involving family members of pediatric can...fits both the family and the medical team, accordi...study. , Riley Hospital for Children, where the...umber of hospitals nationwide routinely offering t...ents the opportunity to join their child,s medical...
(Date:11/24/2009)... ability reduced in those with undesirable blood l...24 (HealthDay News) -- Abnormal cholesterol levels...ure, a new study has found. , U.S. researchers ...l Heart, Lung, and Blood Institute,s Framingham He...4, had coronary heart disease at the start of the ...
(Date:11/24/2009)... Laser-type device to be coupled... San Diego, CA (PRWEB) November 24, 2009 -- Ente...it has initiated discussions with a manufacturer o...y laser device which shall be owned by Entest and ...es currently being developed by Entest. These ther...
(Date:11/24/2009)... Web content and Internet market...free leads through your website. , ...en another tough year for the U.S. economy. Small ...ng the strain to keep their businesses afloat and ...pping block are things like training or marketing ...
(Date:11/24/2009)... 2009Q3Financials,S-1RegistrationStatementbeingPr... ,, WESTON,Fla.,Nov.24/PRNewswire-FirstCall/--...theCompany")ispleasedtomakeavailableacurrentcorpor...ncialsonPinksheetsrecently,ASRhasbeendiligentinacc...rmbusinessplanfortheCompany. ,, Aspartofthisong...
Breaking Medicine News(10 mins):Health News:Involving family in medical rounds benefits both family and medical team 2Health News:Involving family in medical rounds benefits both family and medical team 3Health News:Involving family in medical rounds benefits both family and medical team 4Health News:Cholesterol Plays Role in Heart Failure Risk 2Health News:Entest Biomedical Enters into Discussions with Laser Manufacturer to Develop Proprietary Photoceutical Device for COPD Treatment 2Health News:We Do Web Content Offers Free Lead Generation Report 2Health News:We Do Web Content Offers Free Lead Generation Report 3Health News:American Scientific Resources Inc. Issues Corporate Update 2Health News:American Scientific Resources Inc. Issues Corporate Update 3
...an Lunden, the nation,s,longest-running morning ne...arly two decades. During her tenure she reported ...lympics, and two Royal weddings. One of the most,...national media campaigns. Lunden,s years in broad...
...welling, loose teeth and exposed bone , , ...n of people taking widely prescribed oral osteopor...e much higher than previously thought, a new study...ible," although there was a noted risk in people t...
... discovered a new syndrome associated with severe ...hich children lack sufficient infection-fighting w...e syndrome: mutations in the gene Glucose-6-phosph... an international team of scientists, composed of ...
...rsity Of Southern California, School Of Dentistry ...isphosphonates to increased jaw necrosis. The stud...t-term use of common oral osteoporosis drugs may l...A ). , Osteoporosis currently affects 10 million ...
...of salicylic acid in study participants , ... acid, the key component that gives aspirin its an... be something humans can produce on their own, a n.... This made sense because salicylic acid is a nat...
...tudy shows that people who are smokers and have a ...ificantly more likely to suffer a stroke from a br... in the December 31, 2008, online issue of Neurol...ke, called subarachnoid hemorrhage, is one of the ...
Other Medicine News:Health News:Joan Lunden Inks Three-Year Deal to Host Health Corner(R) Television Series 2Health News:Study Links Osteoporosis Drugs to Jaw Trouble 2Health News:Study Links Osteoporosis Drugs to Jaw Trouble 3Health News:Scientists identify new congenital neutropenia syndrome and causative gene mutation 2Health News:Scientists identify new congenital neutropenia syndrome and causative gene mutation 3Health News:USC dentist links Fosomax-type drugs to jaw necrosis 2Health News:Smokers with stroke in the family 6 times more likely to have stroke too 2
(Date:11/24/2009)...re-FirstCall/--KeryxBiopharmaceuticals,Inc.(Nasdaq...hiefExecutiveOfficer,isscheduledtopresentatthePipe...ewYorkCity. ,, Mr.Bentsur,spresentationwillbewe...beaccessiblefromtheInvestorInformationpageoftheCom...ivedversionofthewebcastwillbeavailablefollowingthe...
(Date:11/23/2009)...swire-USNewswire/--FebeDurango-Rueda,52,aColombian...ginaschemetodefraudtheExport-ImportBankoftheUnited...stantAttorneyGeneraloftheCriminalDivisionLannyA.Br...eEx-ImBank,OfficeoftheInspectorGeneral. ,, Dura...istrictCourtinWashingtontoaone-countcriminalinform...
(Date:11/23/2009)...ewswire-FirstCall/--BostonScientificCorporation(NY...HealthCareConference,December1-2. ,, RayElliott...tiveVicePresidentandChiefFinancialOfficer,willpart...day,December1st,beginningatapproximately9:00a.m.E....letoallinterestedpartiesatBostonScientific,swebsit...
Breaking Medicine Technology:Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Colombian National Pleads Guilty to Role in Defrauding the Export-Import Bank of the United States of More Than $1 Million 2Micromet to Host Conference Call and Webcast to Discuss MT110 Data Presented at ECCO ESMO on September 22 2009 14130 1Micromet to Host Conference Call and Webcast to Discuss MT110 Data Presented at ECCO ESMO on September 22 2009 14130 2Micromet to Host Conference Call and Webcast to Discuss MT110 Data Presented at ECCO ESMO on September 22 2009 14130 3Trust for Americas Health Applauds HHS Announcement of Prevention and Wellness Fund of the American Recovery and Reinvestment Act 57556 1Trust for Americas Health Applauds HHS Announcement of Prevention and Wellness Fund of the American Recovery and Reinvestment Act 57556 2Gambling Addiction Expert Says Treatment Tops Prohibition 57554 1Gambling Addiction Expert Says Treatment Tops Prohibition 57554 2
...o 450 days in patients who received eith...rch 29 The investigational,antiplatelet drug pras...atistically significant reduction in the risk of c...r physicians and patients with,potentially fatal c...compared to standard therapy with clopidogrel (Pla...
...ytherapy as NeoVista Progresses wit...ch 28 NeoVista, Inc. released,today to the eye co...y,study of the company,s novel epiretinal brachyth...neration (AMD) at the 31st Annual Macula Society,M...from the study, which,was initiated by NeoVista to...
Other Medicine Technology:Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 2Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 3Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 4Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 5Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 6Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel 7NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society 2NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society 3
Bandeau Bra
Medical Cotton Bra
Compression Bra
Universal Breast Augmentation Support
Medicine Products: